Bellomo Rosa Grazia, Paolucci Teresa, Saggino Aristide, Pezzi Letizia, Bramanti Alessia, Cimino Vincenzo, Tommasi Marco, Saggini Raoul
Department of Biomolecular Sciences, University of Study of Urbino Carlo Bo, Urbino, Italy.
Unit of Physical Medicine and Rehabilitation, Department of Oral Medical Science and Biotechnology (DSMOB), "G. D'Annunzio" University of Chieti-Pescara, Chieti, Italy.
J Cent Nerv Syst Dis. 2020 Dec 13;12:1179573520979866. doi: 10.1177/1179573520979866. eCollection 2020.
Telerehabilitation (TR) in chronic stroke patients has emerged as a promising modality to deliver rehabilitative treatment-at-home. The primary objective of our methodical clinical study was to determine the efficacy of a novel rehabilitative device in terms of recovery of function in daily activities and patient satisfaction and acceptance of the medical device provided.
A 12-week physiotherapy program (balance exercises, upper and lower limb exercises with specific motor tasks using a biofeedback system and exergaming) was administered using the WeReha device. Twenty-five ( = 25) chronic stroke outpatients were enrolled, and the data of 22 patients was analyzed. Clinical data and functional parameters were collected by Berg Balance scale (BBS), Barthel Index (BI), Fugl-Meyer scale (FM), Modified Rankin scale (mRS), and Technology Acceptance Model (TAM) questionnaire at baseline (T0), after treatment (T1), and at the 12-week follow-up (T2). Statistical tests were used to detect significant differences ( < .05), and Cohen's (Co) value was calculated.
BI scores improved significantly after treatment ( = .036; Co 0.776, medium), as well as BBS scores ( = .008; Co 1.260, high). The results in FM scale ( = .003) and mRS scores ( = .047) were significant post treatment. Follow-up scores remained stable across all scales, except the BI. The A and C sub-scales of the TAM correlated significantly to only a T2 to T1 difference for BI scores with = .021 and = .042.
Currently, the WeReha program is not the conventional therapy for stroke patients, but it could be an integrative telerehabilitative resource for such patients as a conventional exercise program-at-home.ClinicalTrials.gov identifier: NCT03964662.
针对慢性中风患者的远程康复（TR）已成为一种有前景的在家进行康复治疗的方式。我们这项系统临床研究的主要目的是确定一种新型康复设备在日常活动功能恢复方面的疗效，以及患者对所提供医疗设备的满意度和接受度。
使用WeReha设备实施了一项为期12周的物理治疗计划（平衡练习、使用生物反馈系统和运动游戏进行特定运动任务的上肢和下肢练习）。招募了25名慢性中风门诊患者，对其中22名患者的数据进行了分析。在基线（T0）、治疗后（T1）和12周随访（T2）时，通过伯格平衡量表（BBS）、巴氏指数（BI）、Fugl-Meyer量表（FM）、改良Rankin量表（mRS）和技术接受模型（TAM）问卷收集临床数据和功能参数。使用统计检验来检测显著差异（<0.05），并计算科恩（Co）值。
治疗后BI评分显著改善（=0.036；Co 0.776，中等），BBS评分也显著改善（=0.008；Co 1.260，高）。治疗后FM量表（=0.003）和mRS评分（=0.047）的结果显著。除BI外，所有量表的随访评分均保持稳定。TAM的A和C子量表仅与BI评分从T2到T1的差异显著相关，分别为=0.021和=0.042。
目前，WeReha计划并非中风患者的传统治疗方法，但作为一种在家进行的传统锻炼计划，它可能成为此类患者的一种综合远程康复资源。ClinicalTrials.gov标识符：NCT03964662。
